1 / 8

Companies Act, 2013 Industry’s perspective on M&A Provisions

Companies Act, 2013 Industry’s perspective on M&A Provisions. 22 February 2014. Equity shares with DVRs - Commonly used instrument for PE/ VC funding Used for various commercial reasons – typically to separate economic interest and voting rights

amos
Download Presentation

Companies Act, 2013 Industry’s perspective on M&A Provisions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Companies Act, 2013Industry’s perspective on M&A Provisions 22 February 2014

  2. Equity shares with DVRs - Commonly used instrument for PE/ VC funding • Used for various commercial reasons – typically to separate economic interest and voting rights • New provisions applicable to private companies also – Draft rules provide: • 3 year dividend (≥10%) track record • 25% limit on issuance • No default in annual filings for 5 years • Impact on future capital structuring for investments in private companies • Grandfathering provisions for past? Funding - Differential equity instruments Not Notified

  3. Convertible Preference Shares popular for PE/ VC funding • Allows for conversion to equity in future, based on agreed valuation parameters • Pro-rata voting rights to accrue, where dividends are not paid for 2 years – Applicable to private companies as well • Impact on commercial arrangement regarding voting rights • Challenges in issuing 0% Preference Shares • Waive voting rights? • Change instrument to Convertible Debentures? • Grandfathering provisions for past? Funding - Voting rights for preference shares Not Notified

  4. Prohibition on insider trading • Extended to unlisted companies • How to quantify impact? • Definition of ‘Securities’ referenced to SCRA – “Marketable securities” • Applicable to Private Companies? • SEBI Insider Trading Regulations – Cooling off period, disclosures, trading window, model code of conduct • Prohibition on forward dealings • No director or KMP to enter into a forward contract for delivery of shares or debentures • Standard provisions in M&A deals - Permitted by RBI and SEBI • Impact assessment required Dealing in shares by KMPs and other personnel Notified

  5. New merger tools Not Notified + Fast track mergers • Simplified procedure - Internal restructuring more time and cost efficient • Clarity required on certain concepts + Cross border mergers • Fund raising opportunities, Efficient cash repatriation, un-winding of holding companies etc • Awaiting alignment of other regulations

  6. Imperative for schemes to receive concerned regulators’ buy-in • Clarity required on regulators, who would receive scheme – Less discretion • Intimation to all the authorities may increase time, cost and effort Merger – Procedural aspects • Threshold prescribed for objections (10% shareholding or 5% debt) - Avoids frivolous litigation and reduces unnecessary delays • Dispensation from creditor meetings – Welcome step; Different positions adopted by different state courts/ judges • Dispensation from shareholder meetings - Thresholds? Not Notified - Intimation to multiple regulators prior to shareholders’ meeting + Objections to scheme Migration from High Court to NCLT – Any grandfathering provisions?

  7. Basic requirement in M&A deals • Entrenchment provisions introduced for Articles • Transfer restrictions inter-se shareholders enforceable in a public company • Correlation of sickness with inability to pay debts – favourable for stakeholders • Earlier “erosion of net worth” criteria subjected to accounting vagaries - Not an appropriate measure; Now removed • Classification as sick company and reference to BIFR • Discomforting for bankers and investors Investment perspectives Not Notified + Recognition to contractual shareholder rights + Revival and rehabilitation of sick companies

  8. Thank you!

More Related